Skip to main content
Top
Published in: Clinical Rheumatology 1/2014

01-01-2014 | Original Article

Noninvasive evaluation of cardiac autonomic modulation in children with primary Raynaud’s phenomenon: a controlled study

Authors: Mehmet Burhan Oflaz, İbrahim Ece, Ayşe Esin Kibar, Şevket Ballı, Demet Alaygut, Ahmet Sami Guven, Fatih Bolat, Fatma Duksal, Ömer Cevit

Published in: Clinical Rheumatology | Issue 1/2014

Login to get access

Abstract

This study aimed to objectively evaluate autonomic nervous function in children with primary Raynaud’s phenomenon (PRP). Thirty-two children with PRP and 30 healthy subjects were included in the study. We analyzed heart rate variability (HRV) in the time domain by the following six standard time-domain measures: standard deviation of all normal R-R intervals during 24 h (SDNN), standard deviation of all normal R-R intervals for all 5-min segments (SDNNi), standard deviation of the average normal R-R intervals for all 5-min segments (SDANN), root mean square of the successive normal R-R interval difference, percentage of successive normal R-R intervals longer than 50 ms, and triangular index (integral of the density distribution of NN intervals divided by the maximum of the density distribution). The mean heart rate throughout 24 h was significantly higher in the PRP group than in the control group (p = 0.001). Although heart rate during the activity period was not significantly different from that during the night period, it was higher in the PRP group than in the control group (p = 0.002). In children with PRP, HRV analysis showed significantly lower values of SDNN (p = 0.01), SDNNi (p = 0.005), SDANN (p = 0.02), and HRV triangular index (p = 0.02) compared with the control group. HRV analysis for sympathovagal balance demonstrated a preponderance for the sympathetic component in patients with PRP. We conclude that all time-domain parameters evaluated in HRV analysis are significantly lower in children with PRP than in healthy subjects.
Literature
2.
go back to reference Raynaud M (1862) De l’asphyxie locale et de la gangrene symetrique des extremites. Rignoux, Paris Raynaud M (1862) De l’asphyxie locale et de la gangrene symetrique des extremites. Rignoux, Paris
5.
go back to reference Duffy CM, Laxer RM, Lee P, Ramsay C, Fritzler M, Silverman ED (1989) Raynaud syndrome in childhood. J Pediatr 114:73–78PubMedCrossRef Duffy CM, Laxer RM, Lee P, Ramsay C, Fritzler M, Silverman ED (1989) Raynaud syndrome in childhood. J Pediatr 114:73–78PubMedCrossRef
6.
go back to reference Kallenberg CG (1992) Raynaud’s phenomenon as an early sign of connective tissue diseases. Vasa Suppl 34:25–28PubMed Kallenberg CG (1992) Raynaud’s phenomenon as an early sign of connective tissue diseases. Vasa Suppl 34:25–28PubMed
7.
go back to reference Fraenkel L (2002) Rayaud’s phenomenon: epidemiology and risk factors. Curr Rheumatol Rep 4:123–128PubMedCrossRef Fraenkel L (2002) Rayaud’s phenomenon: epidemiology and risk factors. Curr Rheumatol Rep 4:123–128PubMedCrossRef
8.
go back to reference Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability; standards of measurement, physiological interpretation, and clinical use. Circulation 93:1043–1065CrossRef Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability; standards of measurement, physiological interpretation, and clinical use. Circulation 93:1043–1065CrossRef
9.
go back to reference LeRoy EC, Medsger TA Jr (1992) Raynaud’s phenomenon: a proposal for classification. Clin Exp Rheumatol 10:485–488PubMed LeRoy EC, Medsger TA Jr (1992) Raynaud’s phenomenon: a proposal for classification. Clin Exp Rheumatol 10:485–488PubMed
10.
go back to reference Pancera P, Sansone S, Presciuttini B, Montagna L, Cerù S, Lunardi C, Lechi A (1999) Autonomic nervous system dysfunction in sclerodermic and primary Raynaud’s phenomenon. Clin Sci 96:49–57PubMedCrossRef Pancera P, Sansone S, Presciuttini B, Montagna L, Cerù S, Lunardi C, Lechi A (1999) Autonomic nervous system dysfunction in sclerodermic and primary Raynaud’s phenomenon. Clin Sci 96:49–57PubMedCrossRef
11.
go back to reference Olsen N, Petring OU, Rossing N (1987) Exaggerated postural vasoconstrictor reflex in Raynaud’s phenomenon. Br Med J 294:1186–1189CrossRef Olsen N, Petring OU, Rossing N (1987) Exaggerated postural vasoconstrictor reflex in Raynaud’s phenomenon. Br Med J 294:1186–1189CrossRef
12.
go back to reference Di Franco M, Paradiso M, Riccieri V, Basili S, Mammarella A, Valesini G (2007) Autonomic dysfunction and microvascular damage in systemic sclerosis. Clin Rheumatol 26:1278–1283PubMedCrossRef Di Franco M, Paradiso M, Riccieri V, Basili S, Mammarella A, Valesini G (2007) Autonomic dysfunction and microvascular damage in systemic sclerosis. Clin Rheumatol 26:1278–1283PubMedCrossRef
14.
go back to reference Nigrovic PA, Fuhlbrigge RC, Sundel RP (2003) Raynaud’s phenomenon in children: a retrospective review of 123 patients. Pediatrics 111:715–721PubMedCrossRef Nigrovic PA, Fuhlbrigge RC, Sundel RP (2003) Raynaud’s phenomenon in children: a retrospective review of 123 patients. Pediatrics 111:715–721PubMedCrossRef
15.
go back to reference Morelli S, Piccirillo G, Fimognani F, Sgreccia A, Ferrante L, Morabito G, De Marzio P, Valesini G, Marigliano V (1996) Twenty-four hour heart period variability in systemic sclerosis. J Rheumatol 23:643–645PubMed Morelli S, Piccirillo G, Fimognani F, Sgreccia A, Ferrante L, Morabito G, De Marzio P, Valesini G, Marigliano V (1996) Twenty-four hour heart period variability in systemic sclerosis. J Rheumatol 23:643–645PubMed
16.
go back to reference Dessein PH, Joffe BI, Metz RM, Millar DL, Lawson M, Stanwix AE (1992) Autonomic dysfunction in systemic sclerosis: sympathetic overactivity and instability. Am J Med 93:143–150PubMedCrossRef Dessein PH, Joffe BI, Metz RM, Millar DL, Lawson M, Stanwix AE (1992) Autonomic dysfunction in systemic sclerosis: sympathetic overactivity and instability. Am J Med 93:143–150PubMedCrossRef
17.
go back to reference Mandl T, Wollmer P, Manthorpe R, Jacobsson LT (2007) Autonomic and orthostatic dysfunction in primary Sjogren’s syndrome. J Rheumatol 34:1869–1874PubMed Mandl T, Wollmer P, Manthorpe R, Jacobsson LT (2007) Autonomic and orthostatic dysfunction in primary Sjogren’s syndrome. J Rheumatol 34:1869–1874PubMed
18.
go back to reference Massin MM, Derkenne B, von Bernuth G (1999) Correlations between indices of heart rate variability in healthy children and children with congenital heart disease. Cardiology 91:109–113PubMedCrossRef Massin MM, Derkenne B, von Bernuth G (1999) Correlations between indices of heart rate variability in healthy children and children with congenital heart disease. Cardiology 91:109–113PubMedCrossRef
19.
go back to reference Ferri C, Emdin M, Giuggioli D et al (1997) Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 h heart rate variability analysis. Br J Rheumatol 36:669–676PubMedCrossRef Ferri C, Emdin M, Giuggioli D et al (1997) Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 h heart rate variability analysis. Br J Rheumatol 36:669–676PubMedCrossRef
20.
go back to reference Wozniak J, Dabrowski R, Luczak D, Kwiatkowska M, Musiej-Nowakowska E, Kowalik I, Szwed H (2009) Evaluation of heart rhythm variability and arrhythmia in children with systemic and localized scleroderma. J Rheumatol 36:191–196PubMed Wozniak J, Dabrowski R, Luczak D, Kwiatkowska M, Musiej-Nowakowska E, Kowalik I, Szwed H (2009) Evaluation of heart rhythm variability and arrhythmia in children with systemic and localized scleroderma. J Rheumatol 36:191–196PubMed
Metadata
Title
Noninvasive evaluation of cardiac autonomic modulation in children with primary Raynaud’s phenomenon: a controlled study
Authors
Mehmet Burhan Oflaz
İbrahim Ece
Ayşe Esin Kibar
Şevket Ballı
Demet Alaygut
Ahmet Sami Guven
Fatih Bolat
Fatma Duksal
Ömer Cevit
Publication date
01-01-2014
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 1/2014
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-013-2393-1

Other articles of this Issue 1/2014

Clinical Rheumatology 1/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.